VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan

Go back to VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
(NASDAQ: VRXA) Delayed: 1.59 -0.01 (0.63%)
Previous Close $1.60    52 Week High
Open $1.62    52 Week Low
Day High $1.65    P/E N/A 
Day Low $1.56    EPS
Volume 189,249